(Q36343077)

13 August 2017

Aligning new interventions with developing country health systems: target product profiles, presentation, and clinical trial design (English)

1 reference

13 August 2017

Alan Brooks

1

1 reference

13 August 2017

Julia K Nunes

2

1 reference

13 August 2017

Andrew Garnett

3

1 reference

13 August 2017

Robin Biellik

4

1 reference

13 August 2017

Didier Leboulleux

5

1 reference

13 August 2017

Ashley J Birkett

6

1 reference

13 August 2017

Christian Loucq

7

1 reference

13 August 2017

11 July 2012

1 reference

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

9

1 reference

13 August 2017

931-945

1 reference

Community perceptions of malaria and vaccines in the South Coast and Busia regions of Kenya

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

A Research Agenda to Underpin Malaria Eradication

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37 °C for seven days

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

30 September 2017

Pricing of new vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Considerations in developing a target product profile for parenteral pharmaceutical products

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

WHO policy development processes for a new vaccine: case study of malaria vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Randomized trials to study the nonspecific effects of vaccines in children in low-income countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Pharmaceutical quality by design: product and process development, understanding, and control

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Access to health care in contexts of livelihood insecurity: a framework for analysis and action

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Storage conditions for stability testing of pharmaceuticals in hot and humid regions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

The introduction of new vaccines into developing countries. IV: Global Access Strategies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Issues in the design and implementation of vaccine trials in less developed countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

A review of the varicella vaccine in immunocompromised individuals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Considerations for combination vaccine development and use in the developing world

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Development and clinical application of new polyvalent combined paediatric vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

How important are airfreight rates and vaccine packaging in cost-saving efforts for the Expanded Programme on Immunization?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3479626

Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation

29 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F17441692.2012.699088

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F17441692.2012.699088

Development of the RTS,S/AS malaria candidate vaccine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F17441692.2012.699088

Product development plan for new vaccine technologies

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22783872

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmaceutical equivalence by design for generic drugs: modified-release products

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22783872

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/17441692.2012.699088

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22783872

1 reference